656 related articles for article (PubMed ID: 35619896)
1. The Aging-Related Prognostic Signature Reveals the Landscape of the Tumor Immune Microenvironment in Head and Neck Squamous Cell Carcinoma.
Chen F; Gong X; Xia M; Yu F; Wu J; Yu C; Li J
Front Oncol; 2022; 12():857994. PubMed ID: 35619896
[TBL] [Abstract][Full Text] [Related]
2. Identification and verification of eight cancer-associated fibroblasts related genes as a prognostic signature for head and neck squamous cell carcinoma.
Dong L; Sun Q; Song F; Song X; Lu C; Li Y; Song X
Heliyon; 2023 Mar; 9(3):e14003. PubMed ID: 36938461
[TBL] [Abstract][Full Text] [Related]
3. A meta-validated immune infiltration-related gene model predicts prognosis and immunotherapy sensitivity in HNSCC.
Ding Y; Chu L; Cao Q; Lei H; Li X; Zhuang Q
BMC Cancer; 2023 Jan; 23(1):45. PubMed ID: 36639648
[TBL] [Abstract][Full Text] [Related]
4. Identification of a metabolic reprogramming-related signature associated with prognosis and immune microenvironment of head and neck squamous cell carcinoma by in silico analysis.
Qiang W; Dai Y; Xing X; Sun X
Cancer Med; 2022 Aug; 11(16):3168-3181. PubMed ID: 35301800
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value and immune landscape of a cuproptosis-related lncRNA signature in head and neck squamous cell carcinoma.
Li YJ; Li HY; Zhang Q; Wei SL
Front Genet; 2022; 13():942785. PubMed ID: 35942287
[No Abstract] [Full Text] [Related]
6. Inflammatory response-related genes predict prognosis in patients with HNSCC.
Jing SL; Afshari K; Guo ZC
Immunol Lett; 2023 Jul; 259():46-60. PubMed ID: 37279805
[TBL] [Abstract][Full Text] [Related]
7. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
Zhu W; Ye Z; Chen L; Liang H; Cai Q
Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154
[TBL] [Abstract][Full Text] [Related]
8. Effects of immune inflammation in head and neck squamous cell carcinoma: Tumor microenvironment, drug resistance, and clinical outcomes.
Zhu L; Wang Y; Yuan X; Ma Y; Zhang T; Zhou F; Yu G
Front Genet; 2022; 13():1085700. PubMed ID: 36579330
[No Abstract] [Full Text] [Related]
9. Identification and verification of aging-related lncRNAs for prognosis prediction and immune microenvironment in patients with head and neck squamous carcinoma.
Gao Q; Shi Y; Sun Y; Zhou S; Liu Z; Sun X; DI X
Oncol Res; 2023; 31(1):35-61. PubMed ID: 37303739
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of novel immune-related genomic biomarkers identified in head and neck squamous cell carcinoma.
Yao Y; Yan Z; Lian S; Wei L; Zhou C; Feng D; Zhang Y; Yang J; Li M; Chen Y
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32719094
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Prognostic Alternative Splicing Reveals the Landscape of Immune Microenvironment in Thyroid Cancer.
Wu J; Sun Y; Li J; Ai M; You L; Shi J; Yu F
Front Oncol; 2021; 11():763886. PubMed ID: 34733794
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of glycosyltransferase related-gene for the diagnosis and prognosis of head and neck squamous cell carcinoma.
He M; Wang L; Yue Z; Feng C; Dai G; Jiang J; Huang H; Ji Q; Zhou M; Li D; Chai W
Aging (Albany NY); 2024 Jan; 16(2):1750-1766. PubMed ID: 38244579
[TBL] [Abstract][Full Text] [Related]
13. Construction and validation of 3-genes hypoxia-related prognostic signature to predict the prognosis and therapeutic response of hepatocellular carcinoma patients.
Liu Y; Shen B; Huang T; Wang J; Jiang J
PLoS One; 2023; 18(7):e0288013. PubMed ID: 37406019
[TBL] [Abstract][Full Text] [Related]
14. Construction and validation of a prognostic model based on stage-associated signature genes of head and neck squamous cell carcinoma: a bioinformatics study.
Chen L; Zhang X; Lin J; Wen Y; Chen Y; Chen CB
Ann Transl Med; 2022 Dec; 10(24):1316. PubMed ID: 36660709
[TBL] [Abstract][Full Text] [Related]
15. Nine-gene signature and nomogram for predicting survival in patients with head and neck squamous cell carcinoma.
Yang F; Zhou LQ; Yang HW; Wang YJ
Front Genet; 2022; 13():927614. PubMed ID: 36092911
[No Abstract] [Full Text] [Related]
16. A novel Pyroptosis-related long non-coding RNA signature for predicting the prognosis and immune landscape of head and neck squamous cell carcinoma.
Zhou C; Shen Y; Jin Y; Shen Z; Ye D; Shen Y; Deng H
Cancer Med; 2022 Dec; 11(24):5097-5112. PubMed ID: 35567376
[TBL] [Abstract][Full Text] [Related]
17. Novel prognostic matrisome-related gene signature of head and neck squamous cell carcinoma.
Huang C; Liang Y; Dong Y; Huang L; Li A; Du R; Huang H
Front Cell Dev Biol; 2022; 10():884590. PubMed ID: 36081907
[No Abstract] [Full Text] [Related]
18. Identification of immune-related lncRNA panel for predicting immune checkpoint blockade and prognosis in head and neck squamous cell carcinoma.
Li Q; Shen Z; Shen Y; Deng H; Shen Y; Wang J; Zhan G; Zhou C
J Clin Lab Anal; 2022 Jun; 36(6):e24484. PubMed ID: 35561269
[TBL] [Abstract][Full Text] [Related]
19. Identification and validation of autophagy-related prognostic signature for head and neck squamous cell carcinoma.
Fang J; Yang Z; Xie J; Li Z; Hu C; Yang M; Zhou X
Transl Oncol; 2021 Jul; 14(7):101094. PubMed ID: 33878525
[TBL] [Abstract][Full Text] [Related]
20. Identification and validation of a prognostic signature of autophagy, apoptosis and pyroptosis-related genes for head and neck squamous cell carcinoma: to imply therapeutic choices of HPV negative patients.
Nan Z; Dou Y; Chen A; Wang K; Sun J; Meng Z; Neckenig M; Ai D; Liu S; Dong Z; Ma C; Cheng Y; Qu X
Front Immunol; 2022; 13():1100417. PubMed ID: 36703967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]